NCT01762059View on ClinicalTrials.gov

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2014

Conditions
Type 1 Diabetes
Interventions
DEVICE

Bi-homonal Bionic Pancreas

A computer algorithm will automatically deliver insulin lispro and glucagon based on the signal from a minimally invasive continuous glucose monitor.

OTHER

Usual care

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Boston University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01762059 - Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas | Biotech Hunter | Biotech Hunter